ReviewJournal of neurology2026
Eye movements and ocular biomarkers in mild traumatic brain injury: from oculomotor pathophysiology to diagnosis and prognosis.
Review in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mild traumatic brain injury (mTBI) is among the most common neurological presentations worldwide, yet its diagnosis remains largely clinical and its prognosis difficult to predict. Structural imaging is typically normal and self-reported symptom scales are insensitive and confounded by effort and comorbidity. Because the generation and control of eye movements recruit an unusually large and anatomically distributed proportion of the brain-from brainstem and cerebellar circuits to parietal, frontal and prefrontal cortices linked by long white-matter tracts-ocular-motor behaviour is sensitive to the diffuse axonal and neurometabolic disturbance that characterises mTBI. This has motivated intense interest in eye movements as objective, quantifiable and increasingly portable biomarkers of injury and recovery. This review examines the anatomical susceptibility, measurement and current evidence base for the principal ocular domains affected in mTBI: saccades, smooth pursuit, fixation, vergence, the vestibulo-ocular reflex, the pupillary light reflex and accommodation. Across domains the literature converges on a recurring pattern in which cognitively demanding tasks reveal deficits that simple reflexive paradigms miss, supporting the view that ocular-motor dysfunction in mTBI is, in large part, a readout of distributed cognitive control rather than focal damage to ocular-motor machinery. We appraise diagnostic accuracy and the relationship between ocular metrics, symptom burden, white-matter integrity and recovery, and we critically address the methodological heterogeneity that currently prevents any single ocular metric from achieving validated-biomarker status. We argue that the most promising path is a standardised, multi-domain composite, validated longitudinally against converging neuroimaging and clinical endpoints, and we set out the methodological agenda required to bring quantitative eye-tracking into routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.